Keyphrases
Positron Emission tomography-CT
100%
Conventional Imaging
100%
Recurrence Site
100%
Oligometastatic Disease
100%
Prostate Cancer Recurrence
100%
18F-fluciclovine
100%
Prostate-specific Antigen Level
30%
Detection Rate
30%
Prostate-specific Antigen
30%
Prostate
20%
Site of Disease
20%
Primary Therapy
20%
Recurrent Disease
20%
Curative Intent
20%
Prostatectomy
20%
Rising Prostate-specific Antigen
20%
Management Plan
20%
Prostate Bed
20%
Initial Treatment
10%
Overall Survival
10%
Positron Emission Tomography
10%
Primary Tumor
10%
Prostate Cancer
10%
Between-group
10%
Disease Burden
10%
Molecular Imaging
10%
Total Prostate-specific Antigen
10%
Lymph Node
10%
Highly Sensitive
10%
Imaging Results
10%
Change Management
10%
Imaging Data
10%
Fisher's Exact Test
10%
Radiotherapy
10%
Anatomical Location
10%
Targeted Treatment
10%
Tumor Control
10%
Organ System
10%
Recurrence Pattern
10%
Primary Outcome Measure
10%
Prior Treatment
10%
New Treatment Options
10%
Extraprostatic
10%
Curative Intent Treatment
10%
Oligometastases
10%
Diverse Patterns
10%
Biochemical Recurrence of Prostate Cancer
10%
Oligometastatic Prostate Cancer
10%
Oligometastatic Patients
10%
CT Detection
10%
Limited Metastatic Disease
10%
Medicine and Dentistry
Positron Emission Tomography
100%
Disease
100%
Prostate Cancer
100%
Recurrent Disease
100%
Cancer Recurrence
100%
Conventional Imaging
100%
Fluciclovine F 18
100%
Prostate Specific Antigen
70%
Prostatectomy
20%
Metastatic Carcinoma
10%
Overall Survival
10%
Primary Tumor
10%
Targeted Therapy
10%
Disease Burden
10%
Molecular Imaging
10%
Radiation Therapy
10%
Lymph Node
10%
Fisher Exact Test
10%
Organ Systems
10%
Biochemical Recurrence
10%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Prostate Cancer
100%
Recurrent Disease
100%
Cancer Recurrence
100%
Fluciclovine F 18
100%
Prostate Specific Antigen
70%
Primary Tumor
10%
Overall Survival
10%
Metastasis
10%
Biochemical Recurrence
10%
Neuroscience
Positron Emission Tomography
100%
Fluciclovine F 18
100%
Prostate Specific Antigen
70%
Prostate
20%
Molecular Imaging
10%
Radiation Therapy
10%
Lymph Node
10%
Immunology and Microbiology
Positron Emission Tomography
100%
Prostate Specific Antigen
70%
Prostate
20%
Lymph Node
10%
Overall Survival
10%
Organ Systems
10%
Molecular Imaging
10%
Disease Burden
10%